IPP Bureau
New support group targets delayed diagnosis of Vasculitis in India
By IPP Bureau - April 20, 2026
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
Energy drinks emerging as hidden driver of liver damage in India’s youth, warn experts
By IPP Bureau - April 20, 2026
Medical experts point to a growing body of research linking energy drinks to liver injury
Lupin subsidiary settles US antitrust case with Humana for $30 Million
By IPP Bureau - April 20, 2026
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
SRM International Hand Conclave 2026 spotlights innovation and collaboration in hand rehabilitation
By IPP Bureau - April 20, 2026
The conclave brought together over 1,000 delegates from across India and internationally
Aurobindo Pharma bags USFDA nod for Glycerol Phenylbutyrate Oral Liquid
By IPP Bureau - April 20, 2026
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
Merck bags EU nod for infant RSV protection in major public health milestone
By IPP Bureau - April 19, 2026
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Takara Bio and Resistomap forge deal to speed up global fight against superbugs
By IPP Bureau - April 19, 2026
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Marengo Asia Hospitals acquires majority stake in Sunshine Global Hospitals
By IPP Bureau - April 18, 2026
Move strengthens footprint in Western India and expands multi-specialty care network
NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes
By IPP Bureau - April 18, 2026
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
ANRF CEO calls for excellence-led innovation at SRMIST Research Day
By IPP Bureau - April 18, 2026
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Cipla receives two observations following USFDA inspection at Goa facility
By IPP Bureau - April 18, 2026
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Experts endorse low-sodium salt substitutes to cut India’s hypertension burden
By IPP Bureau - April 18, 2026
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Department of Biotechnology invites applications for DBT Research Associateship 2025–26
By IPP Bureau - April 18, 2026
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem
By IPP Bureau - April 18, 2026
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
Summer heat may strain liver health, say doctors on World Liver Day
By IPP Bureau - April 18, 2026
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
